Robust cullin-RING ligase function is established by a multiplicity of poly-ubiquitylation pathways

  1. Spencer Hill
  2. Kurt Reichermeier
  3. Daniel C Scott
  4. Lorena Samentar
  5. Jasmin Coulombe-Huntington
  6. Luisa Izzi
  7. Xiaojing Tang
  8. Rebeca Ibarra
  9. Thierry Bertomeu
  10. Annie Moradian
  11. Michael J Sweredoski
  12. Nora Caberoy
  13. Brenda A Schulman
  14. Frank Sicheri
  15. Mike Tyers
  16. Gary Kleiger  Is a corresponding author
  1. University of Nevada, Las Vegas, United States
  2. Genentech Inc, United States
  3. St Jude Children's Research Hospital, United States
  4. University of Montreal, Canada
  5. Mount Sinai Hospital, Canada
  6. California Institute of Technology, United States

Abstract

The cullin-RING ligases (CRLs) form the major family of E3 ubiquitin ligases. The prototypic CRLs in yeast, called SCF enzymes, employ a single E2 enzyme, Cdc34, to build poly-ubiquitin chains required for degradation. In contrast, six different human E2 and E3 enzyme activities, including Cdc34 orthologs UBE2R1 and UBE2R2, appear to mediate SCF-catalyzed substrate polyubiquitylation in vitro. The combinatorial interplay of these enzymes raises questions about genetic buffering of SCFs in human cells and challenges the dogma that E3s alone determine substrate specificity. To enable the quantitative comparisons of SCF-dependent ubiquitylation reactions with physiological enzyme concentrations, mass spectrometry was employed to estimate E2 and E3 levels in cells. In combination with UBE2R1/2, the E2 UBE2D3 and the E3 ARIH1 both promoted SCF-mediated polyubiquitylation in a substrate-specific fashion. Unexpectedly, UBE2R2 alone had negligible ubiquitylation activity at physiological concentrations and the ablation of UBE2R1/2 had no effect on the stability of SCF substrates in cells. A genome-wide CRISPR screen revealed that an additional E2 enzyme, UBE2G1, buffers against the loss of UBE2R1/2. UBE2G1 had robust in vitro chain extension activity with SCF, and UBE2G1 knockdown in cells lacking UBE2R1/2 resulted in stabilization of the SCF substrates p27 and CYCLIN E as well as the CUL2-RING ligase substrate HIF1a. The results demonstrate the human SCF enzyme system is diversified by association with multiple catalytic enzyme partners.

Data availability

High through-put sequence data can be found at the GEO repository: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE136175

The following data sets were generated

Article and author information

Author details

  1. Spencer Hill

    Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, United States
    Competing interests
    No competing interests declared.
  2. Kurt Reichermeier

    Departments of Discovery Proteomics and Discovery Oncology, Genentech Inc, South San Francisco, United States
    Competing interests
    Kurt Reichermeier, is an employee of the Genetech Biotechnology Compnay.
  3. Daniel C Scott

    Department of Structural Biology, St Jude Children's Research Hospital, Memphis, United States
    Competing interests
    No competing interests declared.
  4. Lorena Samentar

    School of Life Sciences, University of Nevada, Las Vegas, Las Vegas, United States
    Competing interests
    No competing interests declared.
  5. Jasmin Coulombe-Huntington

    Institute for Research in Immunology and Cancer, Department of Medicine, University of Montreal, Montreal, Canada
    Competing interests
    No competing interests declared.
  6. Luisa Izzi

    Institute for Research in Immunology and Cancer, Department of Medicine, University of Montreal, Montreal, Canada
    Competing interests
    No competing interests declared.
  7. Xiaojing Tang

    Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada
    Competing interests
    No competing interests declared.
  8. Rebeca Ibarra

    Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, United States
    Competing interests
    No competing interests declared.
  9. Thierry Bertomeu

    Institute for Research in Immunology and Cancer, Department of Medicine, University of Montreal, Montreal, Canada
    Competing interests
    No competing interests declared.
  10. Annie Moradian

    Proteome Exploration Laboratory, Division of Biology and Biological Engineering, Beckman Institute, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0407-2031
  11. Michael J Sweredoski

    Proteome Exploration Laboratory, Division of Biology and Biological Engineering, Beckman Institute, California Institute of Technology, Pasadena, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0878-3831
  12. Nora Caberoy

    School of Life Sciences, University of Nevada, Las Vegas, Las Vegas, United States
    Competing interests
    No competing interests declared.
  13. Brenda A Schulman

    Department of Structural Biology, St Jude Children's Research Hospital, Memphis, United States
    Competing interests
    No competing interests declared.
  14. Frank Sicheri

    Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada
    Competing interests
    Frank Sicheri, is a founder and consultant for Repare Therapeutics.
  15. Mike Tyers

    Institute for Research in Immunology and Cancer, Department of Medicine, University of Montreal, Montreal, Canada
    Competing interests
    No competing interests declared.
  16. Gary Kleiger

    Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, United States
    For correspondence
    gary.kleiger@unlv.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3924-1680

Funding

National Institutes of Health (2 R15 GM117555-02)

  • Spencer Hill
  • Rebeca Ibarra
  • Gary Kleiger

National Institutes of Health (R37GM069530)

  • Daniel C Scott
  • Brenda A Schulman

National Institutes of Health (P30CA021765)

  • Daniel C Scott
  • Brenda A Schulman

St. Jude Children's Research Hospital (ALSAC)

  • Daniel C Scott
  • Brenda A Schulman

Max-Planck-Gesellschaft

  • Brenda A Schulman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Ivan Dikic, Goethe University Frankfurt, Germany

Version history

  1. Received: August 17, 2019
  2. Accepted: December 22, 2019
  3. Accepted Manuscript published: December 23, 2019 (version 1)
  4. Version of Record published: January 22, 2020 (version 2)

Copyright

© 2019, Hill et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,798
    views
  • 523
    downloads
  • 31
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Spencer Hill
  2. Kurt Reichermeier
  3. Daniel C Scott
  4. Lorena Samentar
  5. Jasmin Coulombe-Huntington
  6. Luisa Izzi
  7. Xiaojing Tang
  8. Rebeca Ibarra
  9. Thierry Bertomeu
  10. Annie Moradian
  11. Michael J Sweredoski
  12. Nora Caberoy
  13. Brenda A Schulman
  14. Frank Sicheri
  15. Mike Tyers
  16. Gary Kleiger
(2019)
Robust cullin-RING ligase function is established by a multiplicity of poly-ubiquitylation pathways
eLife 8:e51163.
https://doi.org/10.7554/eLife.51163

Share this article

https://doi.org/10.7554/eLife.51163

Further reading

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Maximilian Nagel, Marco Niestroj ... Marc Spehr
    Research Article

    In most mammals, conspecific chemosensory communication relies on semiochemical release within complex bodily secretions and subsequent stimulus detection by the vomeronasal organ (VNO). Urine, a rich source of ethologically relevant chemosignals, conveys detailed information about sex, social hierarchy, health, and reproductive state, which becomes accessible to a conspecific via vomeronasal sampling. So far, however, numerous aspects of social chemosignaling along the vomeronasal pathway remain unclear. Moreover, since virtually all research on vomeronasal physiology is based on secretions derived from inbred laboratory mice, it remains uncertain whether such stimuli provide a true representation of potentially more relevant cues found in the wild. Here, we combine a robust low-noise VNO activity assay with comparative molecular profiling of sex- and strain-specific mouse urine samples from two inbred laboratory strains as well as from wild mice. With comprehensive molecular portraits of these secretions, VNO activity analysis now enables us to (i) assess whether and, if so, how much sex/strain-selective ‘raw’ chemical information in urine is accessible via vomeronasal sampling; (ii) identify which chemicals exhibit sufficient discriminatory power to signal an animal’s sex, strain, or both; (iii) determine the extent to which wild mouse secretions are unique; and (iv) analyze whether vomeronasal response profiles differ between strains. We report both sex- and, in particular, strain-selective VNO representations of chemical information. Within the urinary ‘secretome’, both volatile compounds and proteins exhibit sufficient discriminative power to provide sex- and strain-specific molecular fingerprints. While total protein amount is substantially enriched in male urine, females secrete a larger variety at overall comparatively low concentrations. Surprisingly, the molecular spectrum of wild mouse urine does not dramatically exceed that of inbred strains. Finally, vomeronasal response profiles differ between C57BL/6 and BALB/c animals, with particularly disparate representations of female semiochemicals.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Claudia D Consalvo, Adedeji M Aderounmu ... Brenda L Bass
    Research Article

    Invertebrates use the endoribonuclease Dicer to cleave viral dsRNA during antiviral defense, while vertebrates use RIG-I-like Receptors (RLRs), which bind viral dsRNA to trigger an interferon response. While some invertebrate Dicers act alone during antiviral defense, Caenorhabditis elegans Dicer acts in a complex with a dsRNA binding protein called RDE-4, and an RLR ortholog called DRH-1. We used biochemical and structural techniques to provide mechanistic insight into how these proteins function together. We found RDE-4 is important for ATP-independent and ATP-dependent cleavage reactions, while helicase domains of both DCR-1 and DRH-1 contribute to ATP-dependent cleavage. DRH-1 plays the dominant role in ATP hydrolysis, and like mammalian RLRs, has an N-terminal domain that functions in autoinhibition. A cryo-EM structure indicates DRH-1 interacts with DCR-1’s helicase domain, suggesting this interaction relieves autoinhibition. Our study unravels the mechanistic basis of the collaboration between two helicases from typically distinct innate immune defense pathways.